Results 241 to 250 of about 759,762 (298)

Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende, Emilien Petit, Young Woo Park, Sophie Tezenas du Montcel, James M. Joers, Jonathan M. DuBois, H. Moore Arnold, Michal Povazan, Ipek Özdemir, Guita Banan, Romain Valabregue, Philipp Ehses, Jennifer Faber, Chiadi U. Onyike, Peter B. Barker, Jeremy D. Schmahmann, Eva‐Maria Ratai, Sub H. Subramony, Thomas H. Mareci, Khalaf O. Bushara, Henry Paulson, Thomas Klockgether, Alexandra Durr, Tetsuo Ashizawa, Christophe Lenglet, Gülin Öz, READISCA Investigators   +26 more
wiley   +1 more source

Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick, Nomin Enkhtsetseg, Joseph Sadok, Matheus Mochetti, Annabel Sorby Adams, Jennifer Guo, Cristina Trapaga Hacker, Isabella Gomez Hjerthen, Seungwon Lee, Siddharth Satish, Andrew S. Ham, Justin Hill, Denis Balaban, Kevin Kyle, Rebecca L. Gillani, Marcelo Matiello, Aleksandar Videnovic, Eric C. Klawiter, W. Taylor Kimberly, Farrah J. Mateen   +19 more
wiley   +1 more source

Drug-Related Problems and Clinical Pharmacist-Led Medication Therapy Management; Three-Year Survey in an Educational Pharmacotherapy Clinic

Valitabar N, Esmaily H, Sistanizad M, Roshanzamiri S, Farrokhian A, Mohammadnezhad G.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Medication Therapy Management Services

Drugs, 2009
In the US, the Medicare Modernization Act of 2003 required that Medicare Part D insurers provide medication therapy management (MTM) services (MTMS) to selected beneficiaries, with the goals of providing education, improving adherence, or detecting adverse drug events and medication misuse. These broad goals and variety in MTM programmes available make
Annette N, Pellegrino, Michelle T, Martin, Jessica J, Tilton, Daniel R, Touchette   +3 more
openaire   +2 more sources

Sound medication therapy management programs

The Case Manager, 2006
This document is endorsed or supported by the following organizations: • AARP • Academy of Managed Care Pharmacy • American College of Clinical Pharmacy • American Geriatrics Society • American Pharmacists Association • American Society of Consultant Pharmacists • Case Management Society of America • College of ...
openaire   +4 more sources

Mitigation of Medication Mishaps via Medication Therapy Management

Annals of Pharmacotherapy, 2009
Background: In 2006. the Center for Medicare & Medicaid Services incorporated the requirement for a Medication Therapy Management Program (MTMP) for individuals with Part D coverage to ensure that drug regimens provide optimal therapeutic outcomes through improved medication use, thereby reducing adverse drug events.
Vanita K, Pindolia, Lesia, Stebelsky, Tanya M, Romain, Lori, Luoma, Sandra N, Nowak, Fadwa, Gillanders   +5 more
openaire   +2 more sources

Reimbursement for medication therapy management services

American Journal of Health-System Pharmacy, 2008
The ambulatory care subcommittee of the University HealthSystem Consortium (UHC) recently surveyed UHC members about medication therapy management (MTM) services. The purpose was to gather information regarding the Medicare prescription drug plans (PDPs) that contract with hospital pharmacies ...
Kelly, Epplen, Laurel M, Marsden, Christine, Murphy   +2 more
openaire   +2 more sources

Positioning and integrating medication therapy management

Journal of the American Pharmacists Association, 2012
To summarize findings from medication therapy management (MTM) "environmental scans" conducted from 2007 through 2010, interpret findings from the environmental scans using insights gained from the Future of MTM Roundtable convened in October 2010, and propose ideas for future positioning and integrating of MTM programs in the U.S.
Jon C, Schommer, William R, Doucette, Kathleen A, Johnson, Lourdes G, Planas   +3 more
openaire   +2 more sources

The medication therapy management pyramid shifting medication review to an integrated medication therapy management process

European Journal of Hospital Pharmacy, 2015
As the population of older people is expanding and medication review is both time consuming and money consuming, a more sophisticated approach to improve patient medication use might be necessary. An integrated combination of several medication therapy management techniques might therefore more efficiently improve medication effectiveness, medication ...
B J F (Bart) van den Bemt, V J H Huiskes
openaire   +1 more source

Medication Therapy Management in Medicare Part D

The Senior Care Pharmacist, 2022
Medication Therapy Management (MTM) is not just a good idea–it is the law. Included in the provisions of the Medicare Modernization Act of 2003 and codified into the Social Security Act is the legal mandate for a program to identify at-risk individuals with chronic disease conditions and an expected consumption of Part D drugs that reached a ...
openaire   +2 more sources